ACTG Highlights

to 28%; the percentage of women rose from 5 to 11%; and the percentage of IVDUs remained fairly stable at
11%. 417 infants and children have been enrolled in ACTG studies.
NIAID has committed a total of $9 million in FY 1990 for three initiatives to make AIDS clinical trials more
accessible to all of these groups: (1) through the AIDS Clinical Trial Infrastructure for Minority Institutions,
cooperative agreement awards will be made to minority institutions not currently involved in the ACTG; (2)
supplements will be awarded to some existing ACTG sites to expand the enrollment of currently underserved
populations; this initiative is a collaboration with the National Institute on Drug Abuse, which is adding an
additional $2 million for sites focusing on intravenous drug users; and (3) supplements will be awarded to
some existing ACTG sites to increase the enrollment of children and pregnant women.
Prepared by:
Office of Communications
National Institute of Allergy
and Infectious Diseases
National Institutes of Health
Bethesda, MD 20892

May 1990